Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StaphVAX in orthopedic prosthetic implant patients
NCT00211926Phase 3Completed
- Sponsor
- Nabi Biopharmaceuticals
- Start
- Dec 2004
- Primary completion
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in staphylococcal infection comparing StaphVAX with Placebo (2 arms). Primary endpoint: serotype-specific antibody concentrations at 6 weeks. Started Dec 2004; status: completed.
02
Drugs
s. aureus type 5 & 8 capsular polysaccharide vaccine
03
Conditions
staphylococcal infection
Beyond the preview
Go deeper on NCT00211926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211926.